OrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Corp KIDS.OQ reported a quarterly adjusted loss of 30 cents per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of nine analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -40 cents to -19 cents per share.
Revenue rose 15.4% to $70.51 million from a year ago; analysts expected $68.25 million.
OrthoPediatrics Corp's reported EPS for the quarter was a loss of 30 cents.
The company reported a quarterly loss of $7.16 million.
OrthoPediatrics Corp shares had risen by 9.1% this quarter and gained 17.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for OrthoPediatrics Corp is $24.00, about 13% above its last closing price of $20.87
This summary was machine generated from LSEG data August 4 at 09:37 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.30 | -0.30 | Met |
Mar. 31 2026 | -0.47 | -0.45 | Beat |
Dec. 31 2025 | -0.34 | -0.43 | Missed |
Sep. 30 2025 | -0.26 | -0.50 | Missed |
Recent news on Orthopediatrics
See all newsOrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Q2 revenue rises 15%, beats estimates
Brief: OrthoPediatrics Q2 EPS USD -0.3
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics beats Q1 revenue estimates, raises 2026 outlook